Abstract
The purpose of this study was to assess the diagnostic accuracy of whole-body MRI (WB-MRI) at 1.5 T or 3 T compared with FDG-PET-CT in the follow-up of patients suffering from colorectal cancer. In a retrospective study, 24 patients with a history of colorectal cancer and suspected tumour recurrence underwent FDG-PET-CT and WB-MRI with the use of parallel imaging (PAT) for follow-up. High resolution coronal T1w-TSE and STIR sequences at four body levels, HASTE imaging of the lungs, contrast-enhanced T1w- and T2w-TSE sequences of the liver, brain, abdomen and pelvis were performed, using WB-MRI at either 1.5 T (n = 14) or 3 T (n = 10). Presence of local recurrent tumour, lymph node involvement and distant metastatic disease was confirmed using radiological follow-up within at least 5 months as a standard of reference. Seventy seven malignant foci in 17 of 24 patients (71%) were detected with both WB-MRI and PET-CT. Both investigations concordantly revealed two local recurrent tumours. PET-CT detected significantly more lymph node metastases (sensitivity 93%, n = 27/29) than WB-MRI (sensitivity 63%, n = 18/29). PET-CT and WB-MRI achieved a similar sensitivity for the detection of organ metastases with 80% and 78%, respectively (37/46 and 36/46). WB-MRI detected brain metastases in one patient. One false-positive local tumour recurrence was indicated by PET-CT. Overall diagnostic accuracy for PET-CT was 91% (sensitivity 86%, specificity 96%) and 83% for WB-MRI (sensitivity 72%, specificity 93%), respectively. Examination time for WB-MRI at 1.5 T and 3 T was 52 min and 43 min, respectively; examination time for PET-CT was 103 min. Initial results suggest that differences in accuracy for local and distant metastases detection using FDG-PET-CT and WB-MRI for integrated screening of tumour recurrence in colorectal cancer depend on the location of the malignant focus. Our results show that nodal disease is better detected using PET-CT, whereas organ disease is depicted equally well by both investigations.
Similar content being viewed by others
References
World Health Organization (2008) Fact sheet no 297 on worldwide cancer. http://www.who.int/mediacentre/factsheets/fs297/en/index.html Accessed 6 Aug 2008
Abir F, Alva S, Longo WE et al (2006) The postoperative surveillance of patients with colon cancer and rectal cancer. Am J Surg 192:100–108
Desch CE, Benson AB, Somerfield MR et al (2005) Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 23:8512–8519
Arriola E, Navarro M, Pares D et al (2006) Imaging techniques contribute to increased surgical rescue of relapse in the follow-up of colorectal cancer. Dis Colon Rectum 49:478–484
Vigano L, Ferrero A, Lo Tesoriere, Capussotti L (2008) Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 15:2458–2464. doi:10.1245/s10434-008-9935-9
Gilliams AR, Lees WR (2008) Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol 19:712–717
Pelosi E, Messa C, Sironi S, Picchio M, Landoni C, Bettinardi V et al (2004) Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study. Eur J Nucl Med Mol Imaging 31:932–939
Cohade C, Osman M, Leal J, Wahl RL (2003) Direct comparison of 18F-FDG-PET and PET-CT in patients with colorectal carcinoma. J Nucl Med 44:1797–803
Even-Sapir E, Parag Y, Lerman H et al (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232:815–822
Kinner S, Antoch G, Bokisch A, Veit-Haibach P (2007) Whole-body PET/CT-colonography: a possible new concept for colorectal cancer staging. Abdom Imaging 32:606–612
Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver. Ann Surg 240:1027–1034
Lauenstein TC, Goehde SC, Herborn CU, Goyen M, Oberhoff C, Debatin JF (2004) Whole-body MR imaging: evaluation of patients for metastases. Radiology 233:139–48
Schmidt GP, Schoenberg SO, Schmid R, Stahl R, Tiling R, Becker CR et al (2006) Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol 17:939–949
Thomson V, Pialat JB, Gay F, Coulon A, Voloch A, Granier A et al (2008) Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between non-contrast and contrast enhanced images. Am J Clin Oncol 31:285–292
Schlemmer HP, Schäfer J, Pfannenberg C, Radny P, Korchidi S, Müller-Horvat C (2005) Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiences. Invest Radiol 40:64–71
Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Reiser MF et al (2005) High-resolution whole-body MRI tumor staging with the use of parallel imaging versus dual modality PET-CT: experience on a 32-channel system. Invest Radiol 40:743–753
Fink C, Puderbach M, Biederer J, Fabel M, Dietrich O, Kauczor HU (2007) Lung MRI at 1.5 and 3 Tesla: observer preference study and lesion contrast using five different pulse sequences. Invest Radiol 42:377–383
Schmidt GP, Wintersperger B, Graser A, Baur-Melnyk A, Reiser MF, Schoenberg SO (2007) High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study. Invest Radiol:449-459
Hargreaves BA, Cunningham CA, Nishimura DG, Conolly SM (2004) Variable rate selective excitation for rapid MRI sequences. J Magn Reson Med 52:590–597
Stehling G, Niederstadt T, Kramer S, Kugel H, Schwindt W, Heindel W et al (2005) Comparison of a T1-weighted inversion recovery-, gradient echo- and spin-echo sequence for imaging of the brain at 3.0 Tesla. Fortschr Roentgenstr 177:536–542
Engelhard K, Hollenbach HP, Wohlfart K, von Imhoff E, Fellner FA (2004) Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol 14:99–105
Brix G, Lechel U, Glatting G, Ziegler SI, Muenzing W, Mueller SP et al (2005) Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG-PET/CT examinations. J Nucl Med 46:608-613
Vanel D, Bittoun J, Tardivon A (1998) MRI of bone metastases. Eur Radiol 8:1345–1351
Danet IM, Semelka RC, Leonardou P, Braga L, Vaidean G, Woosley JT et al (2003) Spectrum of MRI appearances of untreated metastases of the liver. Am J Roentgenol 181:809–817
Beggs AD, Hain SF, Curran KM, O’Doherty MJ (2002) FDG-PET as a “metabolic biopsy” tool in non-lung lesions with indeterminate biopsy. Eur J Nucl Med Mol Imaging 29:542–546
Welsh JS, Kennedy AS, Thomadsen B (2006) Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 66:S62–S73
Curati WL, Halevy A, Gibson RN, Carr DH, Blumgart LH, Steiner RE (1988) Ultrasound, CT and MRI comparison in primary and secondary tumors of the liver. Gastrointest Radiol 13:121–123
Chen LB, Tong JL, Song HZ, Zhu H, Wang YC (2007) (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer. World J Gastroenterol 13:5025–5029
Votrubova J, Belohlavek O, Jaruskova M, Oliverius M, Lohynska R, Trskova K et al (2006) The role of FDG-PET/CT in the detection of recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 33:779–784
Diederich S, Semik M, Lentschig MG, Winter F, Scheld HH, Roos N et al (1999) Helical CT of pulmonary nodules in patients with extrathoracic malignancy: CT-surgical correlation. Am J Roentgenol 172:353–360
Frericks BB, Meyer BC, Martus P, Wendt M, Wolf KJ, Wacker F (2008) MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multi-detector computed tomography (MDCT). J Magn Reson Med:538-545
Bruegel M, Gaa J, Woertler K, Ganter C, Waldt S, Hillerer C, Rummeny EJ (2007) MRI of the lung: value of different turbo spin-echo, single-shot turbo spin-echo, and 3D gradient-echo pulse sequences for the detection of pulmonary metastases. J Magn Reson Imaging 25:73–81
Juergens KU, Weckesser M, Stegger L, Franzius C, Beetz M, Schober O et al (2006) Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules. Eur Radiol 16:1131–1137
Emmott J, Sanghera B, Chambers J, Wong WL (2008) The effects of N-butylscopolamine on bowel uptake: an 18F-FDG PET study. Nucl Med Commun 29:11–16
Schiepers C, Pennickx F, de Vadder N, Merckx E, Mortlemans L, Bormans G et al (1995) Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol 21:517–522
Dicle O, Obuz F, Cakmakci H (1999) Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging. Br J Radiol 72:1155–1159
Titu LV, Nicholson AA, Hartley JE et al (2006) Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer. Ann Surg 243:348–352
Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J et al (2003) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199–3206
Squillaci E, Manenti G, Mancino S, Ciccio C, Calabria F, Danieli R et al (2008) Staging of colon cancer: whole-body MRI vs whole-body PET-CT-initial clinical experience. Abdom Imaging 33:676–688. doi:10.1007/s00261-007-9347-5
Brennan DD, Gleeson T, Coate LE, Cronin C, Carney D, Eustace SJ (2005) A comparison of whole-body MRI and CT for the staging of lymphoma. AJR 185:711–716
Takahara T, Imay Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M (2004) Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22:275–282
Muertz P, Krautmacher C, Traeber F, Gieseke J, Schild HH, Willinek WA (2007) Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol 17(12):3031–3037
Lichy MP, Aschoff P, Plathow C, Stemmer A, Horger W, Mueller-Horvath C et al (2007) Tumor detection by diffusion-weighted MRI and ADC-mapping—initial clinical experiences in comparison to PET-CT. Invest Radiol 42:605–613
Mehta RC, Marks MP, Hinks RS, Glover GH, Enzmann DR (1995) MR evaluation of vertebral metastases: T1-weighted short inversion time inversion recovery, fast spin echo, and inversion-recovery fast spin-echo sequences. Am J Neuroradiol 16:281–288
Semelka RC, Martin DR, Balci C, Lance T (2001) Focal liver lesions: comparison of dual-phase CT and multi-sequence multi-planar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13:397–401
Dobritz M, Radkow T, Nittka M, Bautz W, Fellner FA (2002) VIBE with parallel acquisition technique—a novel approach to dynamic contrast-enhanced MR imaging of the liver. Fortschr Roentgenstr 174:738.41
Vogt FM, Herborn CU, Hunold P et al (2004) HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT. AJR 183:71–78
Frericks BB, Meyer BC, Martus P, Wendt M, Wolf KJ, Wacker F (2008) MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multi-detector computed tomography (MDCT). J Magn Reson Imaging 27:538–545
Schmidt GP, Wintersperger B, Graser A, Baur-Melnyk A, Reiser MF, Schoenberg SO (2007) High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study. Invest Radiol 42:449–459
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmidt, G.P., Baur-Melnyk, A., Haug, A. et al. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 19, 1366–1378 (2009). https://doi.org/10.1007/s00330-008-1289-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-008-1289-y